Pseudoxanthoma Elasticum Is a Metabolic Disease  by Jiang, Qiujie et al.
Pseudoxanthoma Elasticum Is a Metabolic Disease
Qiujie Jiang1, Masayuki Endo2, Florian Dibra1, Krystle Wang1 and Jouni Uitto1
Pseudoxanthoma elasticum (PXE) is a pleiotropic multisystem disorder affecting skin, eyes, and the
cardiovascular system with progressive pathological mineralization. It is caused by mutations in the ABCC6
gene expressed primarily in the liver and kidneys, and at very low levels, if at all, in tissues affected by PXE.
A question has arisen regarding the pathomechanism of PXE, particularly the ‘‘metabolic’’ versus the ‘‘PXE cell’’
hypotheses. We examined a murine PXE model (Abcc6/) by transplanting muzzle skin from knockout (KO)
and wild-type (WT) mice onto the back of WT and KO mice using mineralization of the connective tissue
capsule surrounding the vibrissae as an early phenotypic biomarker. Grafting of WT mouse muzzle skin onto
the back of KO mice resulted in mineralization of vibrissae, whereas grafting KO mouse muzzle skin onto
WTmice did not. Thus, these findings implicate circulatory factors as a critical component of the mineralization
process. This mouse grafting model supports the notion that PXE is a systemic metabolic disorder with
secondary mineralization of connective tissues and that the mineralization process can be countered or even
reversed by changes in the homeostatic milieu.
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INTRODUCTION
Pseudoxanthoma elasticum (PXE; OMIM 264800) is a multi-
system disorder characterized by progressive mineralization
of connective tissues, primarily affecting the elastic structures
in the skin, Bruch’s membrane of the retina, and the mid-
layers of the arterial blood vessels (Ringpfeil et al., 2001;
Neldner and Struk, 2002; Li et al., 2008a). PXE is caused by
mutations in the ABCC6 gene which encodes ABCC6, a
protein belonging to the family of ATP-binding cassette
proteins (Pfendner et al., 2007, 2008). ABCC6 is expressed
primarily in the basolateral surface of the hepatocytes, to a
lesser extent in the proximal tubules of the kidneys, and at a
very low level, if at all, in resident cells, such as fibroblasts
and smooth muscle cells, in tissues affected by PXE (Belinsky
and Kruh, 1999; Scheffer et al., 2002; Matsuzaki et al., 2005).
On the basis of structural homology with other ABCC
transporters, particularly ABCC1, the prototype of C family
of these proteins, ABCC6 has been suggested to serve as an
efflux transporter molecule, and in vitro experiments have
suggested that glutathione-conjugated anionic molecules can
serve as transport substrates (Belinsky et al., 2002; Ilia´s et al.,
2002). However, the precise function of ABCC6 and its
physiologic substrates in vivo remain unknown, and the
pathomechanistic details leading from ABCC6 mutations to
aberrant mineralization in peripheral tissues remain to be
explored. Furthermore, PXE shows considerable phenotypic
variability, and a number of modifying factors, both genetic
and environmental, have been identified (Neldner and Struk,
2002; Zarbock et al., 2007; Hendig et al., 2007, 2008).
Two general mechanisms have been proposed to explain
the consequences of the ABCC6 mutations in PXE as
manifested by mineralization of the elastic structures and
collagen fibers in the skin, the eyes, and the cardiovascular
system. ‘‘The metabolic hypothesis’’ postulates that in the
absence of functional ABCC6 activity, primarily in the liver,
there are changes in the levels of circulating factor(s) that are
physiologically required to prevent unwanted mineralization
(Uitto et al., 2001; Jiang et al., 2007). The clinical observations
and our PXE mouse model studies (see below) support the
metabolic hypothesis, indicating that PXE is a late-onset, slowly
progressing condition. Demonstrations that serum from PXE
patients and mice lack the capacity to prevent calcium/
phosphate precipitation in an in vitro assay utilizing smooth
muscle cell cultures (Jiang et al., 2007) further support of this
hypothesis. In addition, serum from patients with PXE has been
shown to modulate the elastin biosynthetic profile in cultured
dermal fibroblasts, further implicating circulatory factors in the
disease process (LeSaux et al., 2006). On the other hand, ‘‘the
PXE cell hypothesis’’ postulates that the lack of ABCC6
expression in the resident cells alters their biosynthetic capacity
and biological profile (Quaglino et al., 2000, 2005). Specifi-
cally, cultured fibroblasts derived from the skin of patients with
PXE demonstrate increased extracellular matrix expression,
enhanced degradative potential, and altered cell–cell and
cell–matrix interactions, associated with changes in their
proliferative capacity. In support of this postulate are also the
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histopathological and ultrastructural observations demonstrat-
ing that the elastic structures that become mineralized in the
skin of patients with PXE are not normal elastic fibers but
appear to have a changed composition. Nevertheless, both
hypotheses lack strong experimental evidences and remain to
be confirmed.
We have developed an Abcc6/ knockout (KO) mouse by
targeted ablation of the corresponding gene (Klement et al.,
2005). These mice show normal natal and postnatal develop-
ment and are morphologically and histologically indistinguish-
able from their wild-type (WT) counterparts during the early
postnatal period. However, at B5 weeks of age, progressive
mineralization affecting soft connective tissues ensues in
homozygous Abcc6/ mice, but not in their heterozygous
littermates or WT counterparts. Electron microscopy revealed
that the mineralization process affects both elastic structures
and collagen fibers (Klement et al., 2005). Specifically, these
mice demonstrate extensive mineralization of connective
tissues in the skin, eyes, and cardiovascular system, that is,
tissues affected in PXE. Thus, these mice recapitulate the
genetic, histopathologic, and ultrastructural features of human
PXE. An intriguing feature of these mice is that the first site of
mineralization is the connective tissue capsule surrounding the
bulb of vibrissae, which then serves as an early biomarker of
the PXE mineralization process in these mice (Klement et al.,
2005; Jiang et al., 2007).
In this study, we have addressed the ‘‘metabolic hypoth-
esis’’ of PXE utilizing the Abcc6/ mice as a model system.
Specifically, we have grafted muzzle skin containing the
vibrissae from WT and KO mice onto the back of KO and WT
mice. The degree of mineralization was evaluated by
histopathology, including special stains for calcium and
phosphate, followed by computerized morphometric analysis.
RESULTS
Experimental designs
Two experimental designs were utilized: one of them was used
to examine potential prevention of ectopic mineralization,
whereas the second one was aimed at examining the potential
of reversal of the mineralization. In the prevention study,
muzzle skin fromWT or KO mice at the age of 4 weeks (before
development of mineral deposits) was transplanted onto the
back of both KO and WT mice; in the reversal study, muzzle
skin from KOmice at the age of 12 weeks (after development of
mineralization) was transplanted onto WT or KO mice.
Assessment of the graft viability
Both designs utilized skin grafts from the muzzle skin either
from WT or Abcc6/ KO mice, which were transplanted
onto the back of either WT or KO mice (Figure 1). The overall
success rate and persistence of the grafts was 83%. At the
time points indicated below, the grafts together with
surrounding recipient skin were removed and examined by
hematoxylin and eosin stain to assess the presence and
viability of the graft. Specifically, the presence of cross
sections of vibrissae, as shown in Figure 1b, was character-
istic of the donor muzzle skin, whereas the adjacent back
skin of the recipient did not have these structures, indicating
the persistence of the graft. The origin of the graft was also
verified by genomic PCR. Specifically, the grafts which
originated from the KO mice demonstrated the presence of a
320 bp PCR product representing the Abcc6/ allele,
whereas the grafts originating from WT mice clearly
demonstrated the presence of 430 bp WT allele of Abcc6
(Figure 1c, groups 1 and 2, respectively).
Progression of mineralization in Abcc6/ mice
In order to establish the reference points of mineralization for
the grafting studies, the progressive nature of ectopic
mineralization of the connective tissue capsule of vibrissae
was examined in Abcc6þ /þ and Abcc6/ mice (Figure 2).
As reported previously (Klement et al., 2005), no mineraliza-
tion can be noted in Abcc6þ /þ mice even up to 2 years of
age, and this was confirmed in our study. Specifically, there
was no evidence of mineralization in Abcc6þ /þ mice at 24
weeks when the capsules were stained with hematoxylin and
eosin, Alizarin Red, or von Kossa stain (Figures 2a,e, and i). In
Abcc6/mice, no evidence of mineralization was noted at 4
weeks, but foci of mineralization were detected at the age of
12 weeks and the mineralization progressively increased in
the subsequent 12 weeks (Figure 2).
Evidence for the metabolic nature of PXE
In the first set of experiments (prevention) addressing the
metabolic hypothesis of PXE, muzzle skin grafts were placed
onto the back of mice at the age of 4 weeks, a time point that
did not show any degree of mineralization in the Abcc6/
mice. Three different experimental groups were studied.
Group 1: muzzle skin from Abcc6þ /þ mouse (donor) was
grafted onto the back of gender- and age-matched Abcc6/
mouse (recipient). Group 2: the same setup as in Group 1,
except that the Abcc6/ mouse was the donor and the
Abcc6þ /þ mouse was the recipient. Group 3: both donor
and recipient were Abcc6þ /þ mice. The grafts were then
examined at 2 months subsequent to the placement of the
graft. When WT mouse muzzle skin was transplanted onto
the back of a recipient KO mouse, evidence of mineralization
could be noted in the connective tissue capsule surrounding
the vibrissae in each mouse (Figures 3a–c, arrows), although
not every vibrissa showed mineralization, the total percent of
mineralized vibrissae being 28.6% of all examined (Table 1).
In contrast, placement of KO mouse muzzle skin onto the
back of WT mice did not reveal any evidence of mineraliza-
tion at 2 months post operatively (Figures 3d–f). Finally,
placement of WT mouse muzzle skin onto the back of
another WT mouse did not result in mineralization (Figures
3g–i), indicating that the mineralization noted in the KO
mouse is not due to surgical manipulation. The results
illustrated in Figure 3 were based on survey of 56, 42, and 12
vibrissae in Groups 1, 2, and 3, respectively. As shown in
Table 1, 16 out of 56 vibrissae grafted from the muzzle skin of
Abcc6þ /þ mice onto the back of Abcc6/ mice (Group 1)
developed characteristic mineralization, whereas no miner-
alization was observed in any of the 42 and 12 vibrissae
examined in Groups 2 and 3, respectively. The connective
tissue mineralization could also be visualized by transmission
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Figure 1. Grafting of muzzle skin to the back of mice. Hair on the back of the recipient mice was clipped and a full thickness skin wound bed
(0.5–1.0 cm in diameter) was prepared. A similar-sized sample of muzzle skin was obtained from the donor mice and grafted into the wound bed on the
back of the recipient mice. The grafts were examined at 2 months after surgery by (a) morphologic observations, (b) by histology using H&E staining,
(c) and by genomic PCR. In (b), the arrows point to cross sections of vibrissae in the graft of the donor mouse muzzle skin whereas they are not present
in the adjacent back skin of the recipient mouse. In (c), the 430-bp band represents the wild-type allele, whereas the 320-bp PCR product is derived from
amplification of knockout (Abcc6/) allele.
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Figure 2. Progressive mineralization of connective tissue capsule of vibrissae in Abcc6/mice with age. Sections of muzzle skin from 24-week-old Abcc6þ /þ
mice as well as from Abcc6/mice at 4, 12, and 24 weeks of age were stained with H&E (top panel), Alizarin Red (middle panel), or von Kossa (bottom panel).
No mineralization was noted in the 24-week-old Abcc6þ /þ mice (a, e and i), nor was there any mineralization in the 4-week-old Abcc6/ mice (b, f and j). In
contrast, mineralization, as reflected by dark purple (top, c and d, arrows), red color (middle, g and h, arrows), or dark brown (bottom, k and l, arrows), was
noted in the 12- and 24-week-old Abcc6/ mice which demonstrated a progressive increase in mineralization with advancing age. Scale bar¼ 100mm.
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electron microscopy of the graft from WT mice muzzle skin
placed on the back of KO mice. Examination of different
areas of tissue revealed that both collagen fibers and elastic
tissue depicted characteristic electron dense mineral deposits
(Figures 3j and k), similar to that seen in humans with PXE
(Ringpfeil et al., 2001; Neldner and Struk, 2002).
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Figure 3. Aberrant mineralization of the connective tissue capsule of vibrissae in grafted skin. Two months after transplantation of grafts from 4-week-old
donor mice onto the back of recipient mice, the grafts were harvested and the mineralization was examined by H&E (a, d and g), Alizarin Red (b, e and h) and
von Kossa (c, f and i) stains, and by transmission electron microscopy (j, k). The connective tissue capsule of vibrissae grafted from the muzzle skin of Abcc6þ /þ
mice onto the back of Abcc6/ mice developed characteristic mineralization (a–c, arrows), whereas no mineralization was observed in the grafts either from
Abcc6/ (d–f) or Abcc6þ /þ (g–i) mice when transplanted onto the back of WT mice. TEM revealed mineralization (asterisks) of both collagen fibers (j) and
elastic structures (k) in the vibrissae of Abcc6þ /þ mice at 2 months after grafting onto Abcc6/ mice. Scale bar¼ 100mm (a–i); 1 mm (j and k).
Table 1. Mineralization of vibrissae in grafted skin1
Group (donor-recipient) Total vibrissae2 (n) Mineralized vibrissae2 (n) Percent mineralized (%)
1. WT-KO
(n=8)
56 16 28.6
2. KO-WT
(n=7)
42 0 0
3. WT-WT
(n=4)
12 0 0
Abbreviations: KO, knockout (Abcc6/) mice; WT, wild-type mice.
1Tissue samples of muzzle skin from the donor mice were grafted on the wound bed on the back of recipient mice at the age of 4 weeks, as shown in
Figure 1. The grafts were analyzed for mineralization two months post grafting by staining with hematoxylin and eosin, Alizarin Red, and von Kossa, as
shown in Figures 3a–i.
2n, number of vibrissae examined.
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The above prevention studies were performed utilizing 8
and 7 individual pairs of mice in Groups 1 and 2,
respectively. The pairs represented the same litter, and the
mice were originally developed on mixed C57/J129 back-
ground and had been crossbred toward C57 genetic
homogeneity for six generations. Nevertheless, 2 and 1 mice
in Groups 1 and 2, respectively, showed histologic evidence
of inflammation, suggesting minor immune incompatibility.
Consequently, similar experiments were performed with
immune deficient Rag 1 mice (Abcc6þ /þ ; Mombaerts
et al., 1992) as the recipients of muzzle skin grafts from
Abcc6/ mice (n¼ 3). Examination of these grafts did not
reveal any evidence of immune reaction and there was no
mineralization, validating the original observations in the
KO-WT group of mice (Group 2).
Collectively, these data clearly imply that PXE does not
result from a localized defect based on abnormalities in the
resident cells in affected tissues, but rather from a change of
metabolite(s) in serum that would physiologically prevent the
mineralization process in ectopic tissue sites.
Potential for reversal of mineralization in PXE
In general, mineralization develops in several stages:
amorphous calcium phosphate is deposited at the early
stages of the process and then gradually transforms into the
less soluble crystalline apatite-like compounds (Carson,
1997). Therefore, in the second set of experiments, aimed
at evaluation of the potential for reversal of the mineraliza-
tion, muzzle skin from Abcc6/mice at the age of 12 weeks,
that is, after the development of mineralization had com-
menced (see Figure 2), was transplanted onto the back of
Abcc6þ /þ or Abcc6/ mice. As a control, the muzzle skin
from Abcc6/ mice at the age of 3 months was also
examined. Quantitation of mineralization of the connective
tissue capsule surrounding the vibrissae revealed clear
evidence of mineralization in KO mice (n¼ 11) at the age
of 3 months, that is, at the time the grafting procedure was
initiated. The difference in the degree of mineralization
among the three groups was significant (P¼0.0154; Krus-
kal–Wallis test; Table 2). Examination of the grafts originating
from the Abcc6/ mice and placed on the back of WT mice
showed significantly less mineralization than those grafts
placed on the back of KO mice (Po0.05; Dunn’s multiple
comparison test). In contrast, the grafts originating from KO
mice and placed on the back of Abcc6/ indicated close to a
2.5-fold increase in the degree of mineralization in the
subsequent 3 months after grafting, as compared to the 3-
month-old mice. However, due to individual variability, this
difference did not reach statistical significance (P40.05;
Table 2). The mean degree of mineralization in the KO-WT
group was about 60% less than that noted in the muzzle skin
of KO mice at the age of 3 months, but this difference was not
statistically significant (P40.05; Table 2).
DISCUSSION
Conclusions and clinical implications
In this study, we have utilized mouse skin transplantation
using a mouse PXE model (Abcc6/). After grafting, vascular
capillaries in the graft regress, whereas new vascular
ingrowth occurs from the wound bed to replace the
regressing vessels (Capla et al., 2006; Matsuo et al., 2007).
The survival of skin grafts is, therefore, dependent on the
reestablishment of an adequate blood circulation ingrown
from the recipient animal. New established capillaries were
also observed in our study (data not shown). Thus, all
survived grafts were supplied by the blood of the recipient
mice. If PXE is a metabolic disorder, one would expect that
the Abcc6/ mouse skin graft would not develop miner-
alization on the Abcc6þ /þ mouse, but the skin from WT
mouse would be mineralized after grafting onto Abcc6/
mouse. This was indeed observed in our experiments,
suggesting that circulating factor(s) in the recipient’s blood
Table 2. Quantitation of mineralization of vibrissae 3 months after being grafted1
Experimental group
(donor-recipient)
Total
vibrissae
per graft2 (n)
Mineralized
vibrissae
per graft2 (n)
Percent
mineralized
(%)
Total area
per graft3
(U 103)
Mineralized
area per
graft3
(U 103)
Area of mineralization
per total area4 (%) Fold5
P-value
(P=0.015 6)
KO-WT (6 months, n=6) 20.17 3.33 21.1 18.597 0.134 0.52±0.24 (0.34; 0–1.28) 0.16 o0.057
40.058
KO-KO (6 months, n=4) 14.25 6.75 47.9 32.366 0.921 3.19±1.28 (2.32; 1.17–6.94) 1.0
KO (3 months, n=11) 10.00 5.64 59.2 82.258 0.996 1.21±0.19 (1.20; 0.37–2.40) 0.40 40.059
Abbreviations: KO, knockout (Abcc6/) mice; WT, wild-type (Abcc6+/+) mice.
1Skin sections from KO mice at the age of 3 months were grafted onto the back of either WT or KO mice. Three months post grafting, the grafts were
removed, stained with hematoxylin and eosin, and examined for mineralization by light microscopy followed by quantitative computerized morphometric
analysis. For comparison, KO mice at 3m of age were examined similarly for mineralization.
2n, numbers of vibrissae examined.
3Units are expressed as pixels per mm2 reflecting the intensity of hematoxylin and eosin stain.
4Values presented as mean±s.e.m. as well as median; range in parenthesis.
5Calculated using the KO-KO group as 1.0.
6The total exact P-value for the Kruskal–Wallis test.
7P-value for comparison between KO-WT and KO-KO groups (Dunn’s multiple comparison test).
8P-value for comparison between KO-WT and KO groups (Dunn’s multiple comparison test).
9P-value for comparison between KO-KO and KO groups (Dunn’s multiple comparison test).
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are critical in determining the degree of mineralization of the
graft, irrespective of graft genotype. It is important to note that
our studies do not shed light on the chemical characteristics
or the mechanistic details of action of the circulatory factors
important in the pathologic mineralization in PXE. Pre-
viously, a number of serum proteins, including matrix gla
protein, fetuin-A, and ankylosis protein, have been shown to
prevent unwanted mineralization under physiologic condi-
tions of mineral homeostasis (see Jiang et al., 2007). More
recently, low-molecular-weight compounds, such as vitamin
K derivatives, alone or conjugated with glutathione, have
emerged as potential effector molecules (Li et al., 2008a).
Finally, the mechanistic details of the mineralization process,
whether humoral or cellular, are not clear. A possibility,
potentially bridging the observations in support of ‘‘meta-
bolic’’ versus ‘‘PXE cell’’ hypothesis, is that the circulatory
factors, or the lack thereof, influence the metabolic profile of
target cells, such as fibroblasts, in the peripheral connective
tissues, thus eliciting the processes leading to ectopic
mineralization (Gheduzzi et al., 2007).
Collectively, this mouse grafting model supports the notion
that PXE is a systemic metabolic disease, and that the
pathologic deposition of minerals in the affected tissues can
be prevented and even reversed under physiologic homeo-
static conditions. These findings may have implications for
future treatment of this, currently intractable, disorder. More
specifically, identification of the critical factor(s) in circulation
influencing the pathologic mineralization of peripheral con-
nective tissues could provide novel strategies to counteract
mineral deposition with subsequent improvement in the
clinical manifestations of PXE (Li et al., 2008a).
MATERIALS AND METHODS
Mice and study design
The PXE mouse model, Abcc6/ KO mouse, was developed by
targeted inactivation of the Abcc6 gene (Klement et al., 2005). The
mice were maintained under pathogen-free conditions and were
handled in accordance with the guidelines for animal experiments
by the Institutional Animal Care and Use Committee of Thomas
Jefferson University. The experiments were initiated when the mice
were 4 or 12 weeks old. The mice were originally developed on
C57/J129 genetic background and crossbred toward C57 genetic
homogeneity for six generations. In each experiment, Abcc6þ /þ and
Abcc6/ mice from the same litter were used. In some experiments,
Rag1 (B6.129S7-Rag1tm1Mom; Abcc6þ /þ ) mice (The Jackson
Laboratory, Bar Harbor, ME) were used as recipients.
Transplant surgical techniques
Grafting surgery was performed in a laminar flow hood using sterile
procedures. General anesthesia was accomplished by isoflurane
delivered by a precision vaporizer. The recipient mouse back skin
was cleaned with sterile saline and shaved. The donor mouse
muzzle skin (0.5–1.0 cm in diameter) was dissected at the level of the
subcutis and then rinsed in calcium- and magnesium-free phosphate
buffered saline (PBS) (pH 7.4) containing antibiotics. The skin was
grafted, within 0.5 hours of harvest, to a wound bed of similar size
that was prepared by removing recipient mouse skin from the side of
the dorsal region (Figure 1a). Xeroform, a nonadherent petrolatum
dressing, was applied on the top of the graft, covered by an adhesive
dressing and left in place for 1 week.
Histopathology and transmission electron microscopy
The graft or muzzle skin was fixed in 10% phosphate-buffered
formalin, embedded in paraffin, sectioned (5 mm), and stained with
hematoxylin and eosin, Alizarin Red, and von Kossa using standard
methods for histopathological analyses. For transmission electron
microscopy, muzzle skin samples were prepared using standard
protocols. Sections were examined and photographed at 80 kV using
a Tecnai 12 transmission electron microscope equipped with a
Gatan US1000 2K Ultrascan digital camera.
Computerized morphometric quantitation of graft
mineralization by histopathology
Computerized morphometric analysis of hematoxylin and eosin-
stained sections of graft was performed as described elsewhere
(LaRusso et al., 2007; Li et al., 2008b). Briefly, seven sections from
each graft were examined with a Nikon model TE2000 microscope
equipped with an AutoQuant Imaging system (Watervliet, New
York, NY). The number of vibrissae, both those with evidence of
mineralization and those without, were determined in 4–20
systemically selected fields, so that the images capture every visible
vibrissa in each section. The degree of mineralization was expressed
as pixels (arbitrary units) per graft and calculated as the percentage of
area of mineralization per total area of vibrissae.
Genotyping
The genotype of the grafts was determined by genomic PCR. DNA
was isolated from a full-thickness graft in the diameter of 2mm. The
PCR was performed with three primers designed for amplification of
the KO (320-bp), WT (430-bp), or both alleles in the same reaction,
as described previously (Klement et al., 2005).
Statistical analysis
Results are given as mean±s.e.m and as median plus range. The
data were analyzed first by Kruskal–Wallis test using Graph Pad
Prism Software (San Diego, CA), followed by Dunn’s Multiple
Comparison Test for the pairwise analyses. Differences were
considered significant if Po0.05.
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